Investigation of the status and recurrence of young non-benign ovarian tumour patients after fertility preservation therapy

WANG Yan,WANG Yue,LI Yi,CUI Heng,WANG Shijun,WANG Jianliu,WEI Lihui

DOI: https://doi.org/10.3969/j.issn.1672-1861.2011.06.008

2011-01-01

Abstract:Objective To investigate the status and recurrence of young non-benign ovarian tumour patients after fertility preservation therapy.Methods Patients who were treated with fertility preservation therapy for borderline or malignant ovarian neoplasms in Peking University People's Hospital from January 2000 to April 2010 with not elder than 40-year-old and nulliparous were analysed retrospectively and followed up about the recurrence.Results There were 57 patients suitable to the selection criteria.The most frequent type was borderline tumors(38 patients,66.7%),and the second was malignant ovarian germ cell tumors(17,29.8%).49 patients(86.0%)had stage I malignant tumors.33 patients(57.9%)were operated with unilateral oophorectomy,and 17 patients(29.8%)with complete staging operation.29 patients(50.9%)received adjuvant chemotherapy.42 patients were followed up successfully for 10～119(median 40.5)months.There was no recurrence in all the malignant patients.8 recurrence(25.0%)were happened in borderline tumors patients,among of which 24 patients had no recurrence.Median disease-free survival time was 21.5 months(recurrence group),40.5 months(no recurrence group)respectively(P<0.05).Pathological feature with micro-papillary architecture was the prognostic factor for recurrence of serous borderline tumors(P<0.05).Conclusions Borderline tumors are the most frequent type in the non-benign ovarian tumour patients who are younger than 40-year-old.Current fertility preservation therapy has some problems.The characteristics of tumors themselves are the main factors related to recurrence.